Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Hepatobiliary Pancreat Dis Int. 2023 May 9;22(5):474–481. doi: 10.1016/j.hbpd.2023.05.003

Figure 4. Fecal cytolysin-positive patients with cirrhosis and acute decompensation or acute-on-chronic liver disease do not have more severe liver disease than cytolysin-negative patients.

Figure 4.

(A) MELD score (n=77). (B) MELD-Na score (n=77). (C) FIB-4 (n=74). (D) ABIC score (n=77). (E) Child-Pugh score (n=74). (F) ACLF grade (n=78). (G) CLIF-C organ failure score (n=78). (H) Hepatic encephalopathy (n=78). (I) ALT (n=78). (J) AST (n=75). (K) GGT (n=77). (L) AP (n=68). ABIC, ‘Age, serum bilirubin, INR, and serum creatinine score’; ACLF, acute-on-chronic liver failure; ALT, alanine aminotransferase; AP, alkaline phosphatase; AST, aspartate aminotransferase; CLIF-C, European Foundation for the study of chronic liver failure; FIB-4, Fibrosis-4 Index; GGT, gamma-glutamyltransferase; HE, hepatic encephalopathy; INR, international normalized ratio; MELD, model for end-stage liver disease; MELD-Na, sodium-adjusted model for end-stage liver disease; OF, organ failure. P value of equal or less than 0.05 was considered as statistically significant.